| __timestamp | Amneal Pharmaceuticals, Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 84615000 | 72471000 |
| Thursday, January 1, 2015 | 109679000 | 89204000 |
| Friday, January 1, 2016 | 118757000 | 106010000 |
| Sunday, January 1, 2017 | 109046000 | 137905000 |
| Monday, January 1, 2018 | 230435000 | 159888000 |
| Tuesday, January 1, 2019 | 289598000 | 158425000 |
| Wednesday, January 1, 2020 | 326727000 | 200677000 |
| Friday, January 1, 2021 | 365504000 | 304759000 |
| Saturday, January 1, 2022 | 399700000 | 377221000 |
| Sunday, January 1, 2023 | 429675000 | 336361000 |
Data in motion
In the competitive landscape of pharmaceuticals, understanding financial trends is crucial. This analysis focuses on the Selling, General, and Administrative (SG&A) expenses of Amneal Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc. from 2014 to 2023. Over this period, Amneal's SG&A expenses surged by approximately 408%, starting from $84.6 million in 2014 to $429.7 million in 2023. In contrast, Supernus experienced a 364% increase, with expenses rising from $72.5 million to $336.4 million.
These trends highlight the evolving strategies and market dynamics influencing these pharmaceutical giants. Understanding these financial shifts can provide valuable insights into their operational priorities and market positioning.
Regeneron Pharmaceuticals, Inc. vs Supernus Pharmaceuticals, Inc.: SG&A Expense Trends
Incyte Corporation and Supernus Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Pharming Group N.V. and Amneal Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Verona Pharma plc or Amneal Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Amneal Pharmaceuticals, Inc. and Merus N.V.
Who Optimizes SG&A Costs Better? Amneal Pharmaceuticals, Inc. or MannKind Corporation
Selling, General, and Administrative Costs: CRISPR Therapeutics AG vs Supernus Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Bausch Health Companies Inc. or Supernus Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Vericel Corporation and Supernus Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing ImmunityBio, Inc. and Supernus Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Supernus Pharmaceuticals, Inc. or Wave Life Sciences Ltd.
Supernus Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.: SG&A Expense Trends